ANIX logo

ANIX
Anixa Biosciences Inc

10,488
Mkt Cap
$102.26M
Volume
62,374.00
52W High
$5.46
52W Low
$2.44
PE Ratio
-9.68
ANIX Fundamentals
Price
$3.05
Prev Close
$3.04
Open
$3.08
50D MA
$2.83
Beta
1.17
Avg. Volume
104,062.09
EPS (Annual)
-$0.3367
P/B
6.77
Rev/Employee
$0.00
$117.85
Loading...
Loading...
News
all
press releases
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting Anixa Biosciences Announces Presentation of its...
PR Newswire·4d ago
News Placeholder
More News
News Placeholder
Anixa Biosciences Highlights Lean Cash Burn, CAR-T Survival Signals, and Phase II Vaccine Plan at Conference
Anixa Biosciences (NASDAQ:ANIX) CEO Dr. Amit Kumar outlined the company's strategy for advancing two clinical-stage oncology programs while maintaining what he described as a "very modest" cash burn during a Water Tower Research conference session moderated by Robert Sassoon, Managing Director of He...
MarketBeat·12d ago
News Placeholder
Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026 Anixa Biosciences to Participate in RedChip's Biotech...
PR Newswire·17d ago
News Placeholder
Anixa Biosciences' (ANIX) "Buy" Rating Reiterated at D. Boral Capital
D. Boral Capital restated a "buy" rating and set a $10.00 price target on shares of Anixa Biosciences in a research report on Wednesday...
MarketBeat·18d ago
News Placeholder
Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026
Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026 Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026 PR...
PR Newswire·19d ago
News Placeholder
Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting...
PR Newswire·20d ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen
Wall Street Zen lowered Anixa Biosciences from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·22d ago
News Placeholder
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase...
PR Newswire·25d ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Given Buy Rating at D. Boral Capital
D. Boral Capital reissued a "buy" rating and set a $10.00 target price on shares of Anixa Biosciences in a report on Tuesday...
MarketBeat·26d ago
News Placeholder
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer Anixa Biosciences Announces...
PR Newswire·27d ago
<
1
2
...
>

Latest ANIX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.